Skip to content

Clinical trials

Observational Fabry Disease trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fabry Disease Phase: Observational Country / region: United Kingdom Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20081
20091
20101
20141
20151
20191
20211
20221
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting4
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chiesi Farmaceutici S.p.A.3
CENTOGENE GmbH Rostock2
Manchester University NHS Foundation Trust2
Brunel University1
Genzyme, a Sanofi Company1
Royal Free Hospital NHS Foundation Trust1
Sangamo Therapeutics1
UK Kidney Association1
University College, London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fabry Disease13
Angiokeratoma1
Atypical Hemolytic Uremic Syndrome1
Bartter Syndrome1
Calciphylaxis1
Cardiomyopathies1
Cystinosis1
Cystinuria1
Dent Disease1
Denys-Drash Syndrome1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.